Keywords: baxter, launch, aralast, after, fda, approval, healthcare

Baxter to launch Aralast after FDA approval

Article | 20 January 2003

Print This

Baxter Healthcare Corp is gearing up to launch Aralast (alpha-1proteinase inhibitor - human) in the USA as a replacement ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in